Baolingbao Biology Co Ltd
SZSE:002286
Gross Margin
Baolingbao Biology Co Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | CN |
Market Cap | 2.5B CNY |
Gross Margin |
8%
|
Country | JP |
Market Cap | 53.2T JPY |
Gross Margin |
34%
|
Country | CH |
Market Cap | 248.1B CHF |
Gross Margin |
46%
|
Country | US |
Market Cap | 96.7B USD |
Gross Margin |
42%
|
Country | US |
Market Cap | 43.9B USD |
Gross Margin |
34%
|
Country | US |
Market Cap | 42.2B USD |
Gross Margin |
46%
|
Country | FR |
Market Cap | 38.1B EUR |
Gross Margin |
47%
|
Country | US |
Market Cap | 40B USD |
Gross Margin |
35%
|
Country | CN |
Market Cap | 254.8B CNY |
Gross Margin |
2%
|
Country | ZA |
Market Cap | 31B Zac |
Gross Margin |
28%
|
Country | CN |
Market Cap | 211B CNY |
Gross Margin |
34%
|
Profitability Report
View the profitability report to see the full profitability analysis for Baolingbao Biology Co Ltd.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Baolingbao Biology Co Ltd's most recent financial statements, the company has Gross Margin of 7.8%.